Mary T. Szela, CEO and President at TriSalus Life Sciences, Inc. (TLSI), sold 20,302 shares at $4.13 ($79K) on 2026-03-11, disclosed to the SEC on 2026-03-20.
Open-market sale of $79k TLSI by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.13 | 4,358 | $18K | 22.7% |
| 2 | $3.85 | 15,944 | $61K | 77.3% |
| Total | $3.91 avg | 20,302 | $79K | 100% |
| Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |
| TLSI | BUY | 2025-01-29 | $50K | — | Filing → |